[go: up one dir, main page]

MX2025014320A - Compuestos nitrogenados aromaticos, metodos de preparacion y usos medicinales - Google Patents

Compuestos nitrogenados aromaticos, metodos de preparacion y usos medicinales

Info

Publication number
MX2025014320A
MX2025014320A MX2025014320A MX2025014320A MX2025014320A MX 2025014320 A MX2025014320 A MX 2025014320A MX 2025014320 A MX2025014320 A MX 2025014320A MX 2025014320 A MX2025014320 A MX 2025014320A MX 2025014320 A MX2025014320 A MX 2025014320A
Authority
MX
Mexico
Prior art keywords
containing compounds
aromatic nitrogen
preparation methods
medicinal uses
medicinal
Prior art date
Application number
MX2025014320A
Other languages
English (en)
Inventor
Gang Liu
Bingwen Jing
Hugh Y Zhu
Original Assignee
Jiangsu Hengrui Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Hengrui Pharmaceuticals Co Ltd filed Critical Jiangsu Hengrui Pharmaceuticals Co Ltd
Publication of MX2025014320A publication Critical patent/MX2025014320A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se divulgan compuestos aromáticos nitrogenados, su método de preparación, las composiciones farmacéuticas que comprenden dichos compuestos y sus usos farmacéuticos para el tratamiento de enfermedades o trastornos relacionados.
MX2025014320A 2023-06-28 2025-11-28 Compuestos nitrogenados aromaticos, metodos de preparacion y usos medicinales MX2025014320A (es)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US202363510715P 2023-06-28 2023-06-28
US202363515945P 2023-07-27 2023-07-27
US202363519666P 2023-08-15 2023-08-15
US202363584310P 2023-09-21 2023-09-21
US202363593402P 2023-10-26 2023-10-26
US202363602473P 2023-11-24 2023-11-24
US202363615961P 2023-12-29 2023-12-29
US202463621267P 2024-01-16 2024-01-16
US202463550688P 2024-02-07 2024-02-07
US202463637087P 2024-04-22 2024-04-22
US202463651685P 2024-05-24 2024-05-24
US202463660300P 2024-06-14 2024-06-14
PCT/CN2024/102582 WO2025002413A1 (en) 2023-06-28 2024-06-28 Aromatic nitrogen-containing compounds, preparation methods and medicinal uses thereof

Publications (1)

Publication Number Publication Date
MX2025014320A true MX2025014320A (es) 2026-01-07

Family

ID=93937500

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2025014320A MX2025014320A (es) 2023-06-28 2025-11-28 Compuestos nitrogenados aromaticos, metodos de preparacion y usos medicinales

Country Status (5)

Country Link
CN (1) CN121002024A (es)
AU (1) AU2024307018A1 (es)
MX (1) MX2025014320A (es)
TW (1) TW202515880A (es)
WO (1) WO2025002413A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2024286830A1 (en) 2023-06-08 2025-12-04 Nimbus Wadjet, Inc. Wrn inhibitors
WO2025215527A2 (en) 2024-04-10 2025-10-16 Novartis Ag Pharmaceutical combinations and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2015011898A (es) * 2013-03-13 2016-05-05 Genentech Inc Compuestos de pirazolo y usos de los mismos.
WO2015135094A1 (en) * 2014-03-13 2015-09-17 Genentech, Inc. Therapeutic compounds and uses thereof
CN113999232B (zh) * 2020-07-28 2025-01-07 南京正大天晴制药有限公司 Mat2a抑制剂

Also Published As

Publication number Publication date
AU2024307018A1 (en) 2025-11-13
WO2025002413A1 (en) 2025-01-02
TW202515880A (zh) 2025-04-16
CN121002024A (zh) 2025-11-21

Similar Documents

Publication Publication Date Title
MX2023009682A (es) Inhibidores de tyk2 y sus usos.
MX2023009685A (es) Inhibidores de tyk2 y sus usos.
MX2021007970A (es) Derivado de 6-oxo-1,6-dihidropiridazina, metodo de preparacion del mismo y uso medico del mismo.
MX2025014320A (es) Compuestos nitrogenados aromaticos, metodos de preparacion y usos medicinales
WO2024120378A3 (en) Triazole compounds, preparation methods and medicinal uses thereof
MX2023003678A (es) Inhibidores de hidroxiesteroide 17beta- deshidrogenasa 13 (hsd17b13) y usos de estos.
MX2023003677A (es) Inhibidores de hidroxiesteroide 17beta- deshidrogenasa 13 (hsd17b13) y usos de estos.
PH12020551043A1 (en) Compounds, compositions, and methods for treatment of diseases involving acidic or hypoxic diseased tissues
MX2025002953A (es) Derivados heteroaromaticos y aromaticos heterobiciclicos para el tratamiento de trastornos relacionados con ferroptosis
PH12022551105A1 (en) Tyk2 pseudokinase ligands
MX2021009555A (es) Ligandos de pseudocinasa tyk2.
ATE369861T1 (de) Pteridin-derivate zur behandlung von erkrankungen im zusammenhang mit tnf-alpha
WO2022175746A8 (en) Tyk2 inhibitors and uses thereof
MX2025005941A (es) Moduladores de la actividad tnf-\03b1
WO2025049274A3 (en) Tetracyclic derivatives, compositions and methods thereof
MX2021011723A (es) Ligandos de pseudocinasa tyk2.
MX2024011254A (es) Moduladores de nlrp3
MX2023010711A (es) Fenalquilaminas y métodos de preparación y uso de las mismas.
MX2020007586A (es) Proceso de fabricacion de moduladores de somatostatina.
MX2024013020A (es) Compuestos de heteroarilo para el tratamiento del dolor
MX2025003515A (es) Moduladores de akt1
MX2022000712A (es) Moduladores de nlrp3.
CR20240514A (es) Compuestos de heteroarilo para el tratamiento del dolor
EP4603148A3 (en) Deuterium-enriched pirfenidone and methods of use thereof
MX2023003675A (es) Inhibidores de hidroxiesteroide 17beta-deshidrogenasa 13 (hsd17b13) y usos de estos.